Discover why
Physicians love TCAR

Dr. Schneider, Dr. Kokosis,

Dr. Kashyap, Dr. Cambria, Dr. Stoner

“I believe this new thing is going to change the face of carotid intervention.”

Dr. Peter Schneider of Kaiser Foundation Hospital, Honolulu, Dr. Angela Kokkosis of Stony Brook Medical, Dr. Vikram Kashyap of University Hospital, Cleveland Medical Center, Dr. Richard Cambria of Steward Health Care, and Dr. Michael Stoner of University of Rochester Medical Center all place TransCarotid Artery Revascularization (TCAR) at the forefront in the evolution of carotid treatment as a result of its benefits.

Watch the inputs of Dr. Schneider, Dr. Kokkosis, Dr. Kashyap, Dr. Cambria, and Dr. Stoner on how TCAR is a more favorable option for doctors and patients.

Dr. Steve Henao

“I would immediately recommend (TCAR) for my patients and my own family.”

Dr. Steve Henao of Heart Hospital Of New Mexico focuses on the mechanics of TransCarotid Artery Revascularization (TCAR), and how flow reversal is a key aspect in the success of this treatment. Dr. Henao explains why he would consider this option for his own family as he discusses the benefits of TCAR.

Take a look at how Dr. Henao highlights how TCAR works and its importance as an option for carotid treatment.

 

 

 

Dr. Stoner, Dr. Melton
and Dr. Landis

“It’s a transformative technology – it’s going to transform carotid disease management”

Dr. Michael Stoner of University of Rochester Medical Center, Dr. Jim Melton of Cardiovascular Health Clinic, and Dr. Gregg Landis of Northwell Health discuss how they’ve adopted TransCarotid Artery Revascularization (TCAR), what they’ve learned through this practice, and how TCAR has transformed their practice as a whole.

Watch Dr. Stoner, Dr. Melton, and Dr. Landis as they focus on how TCAR has transformed their practice and how they believe it is the evolution of future carotid treatments.

Discover why
Patients love TCAR

Hear the stories from TCAR patients and what they experienced in their journey to address their carotid disease.